Infection with HIV-1

BMJ

Volumn 317, Issue 7168, 1998, Pages 1297-

  Graham, Barney S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; ANTIRETROVIRUS AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 2; LIPID; NEUTRALIZING ANTIBODY; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

CD4+ T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; REVIEW; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASTHENIA; BONE MARROW SUPPRESSION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; GASTROINTESTINAL SYMPTOM; HEADACHE; HYPERLIPIDEMIA; LATENT VIRUS INFECTION; LIPODYSTROPHY; NONHUMAN; OPPORTUNISTIC INFECTION; PANCREATITIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PUBLIC HEALTH; RASH; SKIN MANIFESTATION; SURVIVAL; T LYMPHOCYTE; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS TRANSMISSION;

AIDS VACCINES; ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HUMANS;

EID: 0032494636     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.317.7168.1297     Document Type: Article

References (37)

1. Finzi D., Siliciano R.F. Viral dynamics in HIV-1 infection.Cell 1998; 93: 665–671.
2. McMichael A. T cell responses and viral escape.Cell 1998; 93: 673–676.
3. Littman D.R. Chemokine receptors: keys to AIDS pathogenesis? Cell 1998; 93: 677–680.
4. Chan D.C., Kim P.S. HIV entry and its inhibition.Cell 1998; 93: 681–684.
5. Cullen B.R. HIV-1 auxiliary proteins: making connections in a dying cell.Cell 1998; 93: 685–692.
6. Kwong P.D., Wyatt R., Robinson J, Sweet R.W., Sodroski J, Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.Nature 1998; 393: 648–659.
7. Wyatt R., Swong P.D., Desjardins E, Sweet R.W., Robinson J, Hendrickson W.A., et al. The antigenic structure of the HIV gp120 envelope glycoprotein.Nature 1998; 393: 705–711.
8. AIDS research updates. Science 1998; 280: 1856–1894.
9. Frankel S.S., Wenig B.M., Burke A.P., Mannan P., Thompson L.D., Abbondanzo S.L., et al. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid.Science 1996; 272: 115–117.
10. Zhu T., Mo H, Wang N, Nam D.S., Cao Y, Koup R.A., et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection.Science 1993; 261: 1179–1181.
11. Van't Wout A.B., Kootstra N.A., Mulder-Kampinga G.A., Albrecht-van Lent N., Scherpbier H.J., Veenstra J, et al. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.J Clin Invest 1994; 94: 2060–2067.
12. Joag S.V., Adany I., Li Z, Foresman L, Pinson D.M., Wang C, et al. Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS.J Virol 1997; 71: 4016–4023.
13. Spira A., Marx P.A., Patterson B.K., Mahoney J, Koup R.A., Wolinsky S.M., et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques.J Exp Med 1996; 183: 215–225.
14. Lafeuillade A., Poggi C, Tamalet C, Profizi N. Human immunodeficiency virus type 1 dynamics in different lymphoid tissue compartments.J Infect Dis 1997; 175: 804–806.
15. Cavert W., Notermans D.W., Staskus K, Wietgrefe S.W., Zupancic M, Gebhard K, et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.Science 1997; 276: 960–964.
16. Perelson A.S., Neumann A.U., Markowitz M., Leonard J.M., Ho D.D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.Science 1996; 271: 1582–1586.
17. Wei X., Ghosh S.K., Taylor M.E., Johnson V.A., Emini E.A., Deutsch P, et al. Viral dynamics in human immunodeficiency virus type 1 infection.Nature 1995; 373: 117–122.
18. Chun T.W., Carruth L., Finzi D, Shen X, DiGiuseppe J.A., Taylor H, et al. Quantitation of latent tissue reservoirs and total body load in HIV-1 infection.Nature 1997; 387: 183–188.
19. Hecht F.M., Grant R.M., Petropoulos C.J., Dillon B., Chesney M.A., Tian H, et al. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.N Engl J Med 1998; 339: 307–311.
20. Delwart E.L., Shpaer E.G., Louwagie J., McCutchan F.E., Grez M, Rubsamen-Waigmann H, et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.Science 1992; 262: 1257–1261.
21. Connors M., Kovacs J, Krevat S, Gea-Banacloche J.C., Sneller M.C., Flanigan M, et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.Nature Med 1997; 3: 533–540.
22. Fluery S., De Boer R.J., Rizzardi G.P., Wolthers K.C., Otto S.A., Welbon C.C., et al. Limited CD3+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy.Nature Med 1998; 4: 794–801.
23. Fowke K.R., Nagelkerke N.J., Kimani J., Simonsen J.N., Anzala A.O., Bwayo J.J., et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya.Lancet 1996; 348: 1347–1351.
24. Rowland-Jones S., Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.Nature Med 1995; 1: 59–64.
25. Clerici M., Levin J.M., Kessler H.A., Harris A, Berzofsky J.A., Landay A.L., et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood.JAMA 1994; 271: 42–46.
26. Pinto L.A., Sullivan J., Berzofsky J.A., Clerici M, Kessler H.A., Landay A.L., et al. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.J Clin Invest 1995; 96: 867–876.
27. Mazzoli S., Trabattoni D, Lo Caputo S, Piconi S, Ble C, Meacci F, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals.Nature Med 1997; 3: 1250–1257.
28. Musey L., Hughes J, Schacker T, Shea T, Corey L, McElrath M.J. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.N Engl J Med 1997; 337: 1267–1274.
29. Koup R.A., Safrit J.T., Cao Y.Z., Andrews C.A., McLeod G., Borkowsky W, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.J Virol 1994; 68: 4650–4655.
30. Borrow P., Lewicki H, Hahn B.H., Shaw G.M., Oldstone M.B. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.J Virol 1994; 68: 6103–6110.
31. Reimann K.A., Tenner-Racz K., Racz P, Montefiori C, Yasutomi Y, Lin W, et al. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques.J Virol 1994; 68: 2362–2370.
32. Yasutomi Y., Reimann K.A., Lord C.I., Miller M.D., Letvin N.L. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.J Virol 1993; 67: 1707–1711.
33. Matano T., Shibata R., Siemon C., Connors M., Lane H.C., Martin M.A., Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.J Virol 1998; 72: 164–169.
34. Graham B.S., Wright P.F. Candidate AIDS vaccines.N Engl J Med 1995; 333: 1331–1339.
35. Graham B.S., Karzon D.T. Preventive HIV vaccines. In: Ed. Merigan TCBartlett JGBolognesi D., eds. Textbook of AIDS medicine. 2nd ed. Baltimore, MD: Williams and Wilkins (in press).
36. Ferrari G., Humphrey W, McElrath M.J., Exler J.L., Duliége A.M., Clements M.L., et al. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.Proc Natl Acad Sci USA 1997; 94: 1396–1401.
37. Schwartz D.H., Castillo R.C., Arango-Jaramillo S., Sharma U.K., Song H.F., Sridharan G. Chemokine-independent in vitro resistance to human immunodeficiency virus (HIV-1) correlating with low viremia in long-term and recently infected HIV-1-positive persons.J Infect Dis 1997; 176: 1168–1174.